H
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Price:
0.34
HKD
4.62%
Market Cap:
HK$175.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Huakang Biomedical Holdings Co Ltd
HKEX:8622
|
HK |
|
C
|
Cognizant Technology Solutions Corp
SWB:COZ
|
US |
|
Vsee Health Inc
NASDAQ:VSEE
|
US |
Cash Flow Statement
Cash Flow Statement
Huakang Biomedical Holdings Co Ltd
Huakang Biomedical Holdings Co Ltd
Currency: CNY
| Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
1
|
0
|
(11)
|
0
|
(4)
|
0
|
(3)
|
0
|
(6)
|
0
|
(4)
|
0
|
|
| Depreciation & Amortization |
3
|
0
|
3
|
0
|
3
|
0
|
3
|
0
|
3
|
0
|
3
|
0
|
|
| Other Non-Cash Items |
(0)
|
0
|
6
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
(0)
|
0
|
|
| Cash Taxes Paid |
2
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(6)
|
(1)
|
(2)
|
(1)
|
(2)
|
(1)
|
1
|
2
|
1
|
(3)
|
(2)
|
(2)
|
|
| Cash from Operating Activities |
(3)
N/A
|
(1)
+81%
|
(4)
-509%
|
(1)
+80%
|
(2)
-200%
|
(1)
+71%
|
1
N/A
|
2
+19%
|
(0)
N/A
|
(3)
-5 954%
|
(3)
-5%
|
(2)
+44%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(2)
|
0
|
(2)
|
0
|
(2)
|
0
|
(1)
|
0
|
(2)
|
0
|
(2)
|
0
|
|
| Other Items |
0
|
(2)
|
0
|
(1)
|
0
|
(2)
|
(5)
|
(6)
|
0
|
(1)
|
(2)
|
0
|
|
| Cash from Investing Activities |
(2)
N/A
|
(2)
+13%
|
(2)
-10%
|
(1)
+30%
|
(2)
-51%
|
(2)
-3%
|
(6)
-189%
|
(6)
-5%
|
(1)
+82%
|
(1)
+34%
|
(4)
-483%
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
7
|
0
|
|
| Net Issuance of Debt |
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
|
| Other |
0
|
(2)
|
0
|
(0)
|
0
|
(2)
|
1
|
2
|
1
|
8
|
0
|
1
|
|
| Cash from Financing Activities |
(1)
N/A
|
(2)
-173%
|
(1)
+32%
|
(0)
+79%
|
(1)
-494%
|
(2)
-19%
|
2
N/A
|
2
+3%
|
1
-57%
|
8
+709%
|
6
-24%
|
1
-85%
|
|
| Change in Cash | |||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Net Change in Cash |
(6)
N/A
|
(4)
+33%
|
(7)
-70%
|
(2)
+67%
|
(6)
-156%
|
(5)
+20%
|
(3)
+37%
|
(3)
-5%
|
(0)
+88%
|
5
N/A
|
(1)
N/A
|
0
N/A
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
(6)
N/A
|
(1)
+88%
|
(6)
-832%
|
(1)
+87%
|
(5)
-495%
|
(1)
+85%
|
0
N/A
|
2
+221%
|
(2)
N/A
|
(3)
-87%
|
(5)
-74%
|
(2)
+66%
|
|
Switch to:
Switch to:
See Also
Discover More
